Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Multiple fractures? 305 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 305 reports of Multiple fractures have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.

305
Reports of Multiple fractures with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
3
Deaths
206
Hospitalizations

How Dangerous Is Multiple fractures From ADALIMUMAB?

Of the 305 reports, 3 (1.0%) resulted in death, 206 (67.5%) required hospitalization, and 2 (0.7%) were considered life-threatening.

Is Multiple fractures Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 305 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Multiple fractures?

EMTRICITABINE\TENOFOVIR DISOPROXIL (8,088) TENOFOVIR DISOPROXIL (6,793) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,102) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,942) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (1,489) DENOSUMAB (415) NEXIUM (346) ETANERCEPT (251) ABATACEPT (217) TOCILIZUMAB (200)

Which ADALIMUMAB Alternatives Have Lower Multiple fractures Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Multiple fractures Reports All Drugs Causing Multiple fractures ADALIMUMAB Demographics